The Access to Medicines Crisis and Bristol Uni

At least ten million lives could be saved every year if existing medicines and vaccines were more available to marginalised and poor communities across the world. Further, insufficient resources are currently directed towards research for neglected tropical diseases; diseases such as malaria, sleeping sickness, and blinding trachoma; partly since these conditions predominantly affect the poor and therefore attract little research and development (R&D) funding from current market mechanisms. Universities have an opportunity and a responsibility to take part in these solutions. Join this petition if you believe the University of Bristol should: (1) Make it a priority to ensure that the medicines it develops are available to the widest possible number of people, including those in developing countries; (2) Promote research into neglected diseases and seek partners, funding and innovative mechanisms to this effect; and (3) Measure the fruits of its research by their impact on human welfare (e.g. getting drugs to the right people, improving the livelihoods of poor communities) as opposed to merely measuring the financial return from research on medicines. Further information on this petition, a subsidiary of that of Universities Allied for Essential Medicines is available at http://www.essentialmedicine.org/add-your-voice/ We strongly encourage you to add your details to the above consensus statement. Thank you for considering our petition and for supporting efforts to bring medicines to those that need them most: the poor and marginalised in our world today.

Sponsor

The Malaria and Neglected Disease Campaign is a Bristol-based student organisation working on the international crisis of research for malaria, neglected diseases and the health of communities in developing countries. To achieve this aim, the group has recently adopted this year the strategy of Universities Allied for Essential Medicines (UAEM). UAEM has a simple two-fold mission: (1) to determine how universities can help ensure that biomedical end products, such as drugs, are made more accessible in poor countries; and (2) to increase the amount of research conducted on neglected diseases, or those diseases predominantly affecting people who are too poor to constitute a market attractive to private-sector R&D investment. Further information about MNDC and UAEM are available in the links section below.

Links

Malaria and Neglected Disease Campaign (Bristol): http://www.medsinbristol.co.uk/mnd/ Universities Allied for Essential Medicines (UAEM - International): http://www.essentialmedicine.org/

Discussion

No comments yet.

join the discussion

Recent signatures

  • username

    Sofia Nilsson, United Kingdom

    7 years ago
  • username

    Dan Towie, United Kingdom

    7 years ago
  • username

    Katie B, United Kingdom

    7 years ago
See more

Petition highlights

There are no highlights yet.